Key Points: Last month, the FDA approved gepotidacin (Blujepa; GSK) to treat uncomplicated urinary tract infections (uUTIs) in female patients aged 12 and older, introducing the first new class of […]
Key Points: Last month, the FDA approved gepotidacin (Blujepa; GSK) to treat uncomplicated urinary tract infections (uUTIs) in female patients aged 12 and older, introducing the first new class of […]
We'll send a verification code to %EMAIL%.
Get the best of The Community Voice directly in your email inbox.
Sending to: